Depression after myocardial infarction

被引：7

作者：

Echols M.R. ^{[1
]}

O'Connor C.M. ^{[1
]}

机构：

[1] Duke University Medical Center, Durham, NC 27710

来源：

Current Heart Failure Reports | 2010年 / 7卷 / 4期

基金：

美国国家卫生研究院;

关键词：

Acute coronary syndrome; Cardiovascular disease; Cognitive therapy; Depression; Heart failure; Myocardial infarction; Selective serotonin reuptake inhibitor;

D O I：

10.1007/s11897-010-0024-6

中图分类号：

学科分类号：

摘要：

Depression is an important disease state that requires significant time and resources to manage properly. The presence of depression in patients with cardiovascular disease has been strongly associated with detrimental effects in terms of morbidity and mortality. Although several large-scale and small studies have evaluated various interventions in the management of depression after myocardial infarction, a significant portion of these data have provided more questions than answers. Although limited, the randomized prospective clinical trial data evaluating interventions for the management of depression after myocardial infarction in patients with ischemic heart disease continue to produce promising findings for progressive and improved management of these devastating diseases. © 2010 Springer Science+Business Media, LLC.

引用

页码：185 / 193

页数：8

共 49 条

[1]

Jiang W., Babyak M.A., Rozanski A., Sherwood A., O'Connor C.M., Waugh R.A., Coleman R.E., Hanson M.W., Morris J.J., Blumenthal J.A., Depression and increased myocardial ischemic activity in patients with ischemic heart disease, American Heart Journal, 146, 1, pp. 55-61, (2003)

[2]

Jiang W., Krishnan R.R., O'Connor C.M., Depression and heart disease: Evidence of a link, and its therapeutic implications, CNS Drugs, 16, pp. 111-127, (2002)

[3]

Carney R.M., Freedland K.E., Jaffe A.S., Frasure-Smith N., Lesperance F., Sheps D.S., Glassman A.H., O'Connor C.M., Blumenthal J.A., Kaufmann P.G., Czajkowski S.M., Depression as a risk factor for post-MI mortality [4], Journal of the American College of Cardiology, 44, 2, (2004)

[4]

O'Connor C.M., Jiang W., Kuchibhatla M., Et al., Antidepressant use, depression, and survival in patients with heart failure, Arch Intern Med, 168, pp. 2232-2237, (2008)

[5]

Pozuelo L., Tesar G., Zhang J., Et al., Depression and heart disease: What do we know, and where are we headed?, Cleve Clin J Med, 76, pp. 59-70, (2009)

[6]

Davidson K.W., Burg M.M., Kronish I.M., Et al., Association of anhedonia with recurrent major adverse cardiac events and mortality 1 year after acute coronary syndrome, Arch Gen Psychiatry, 67, pp. 480-488, (2010)

[7]

O'Connor C.M., Glassman A.H., Harrison D.J., Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction, J Clin Psychiatry, 66, pp. 346-352, (2005)

[8]

Jiang W., Impacts of depression and emotional distress on cardiac disease, Cleve Clin J Med, 75, SUPPL. 2, (2008)

[9]

Barefoot J.C., Helms M.J., Mark D.B., Et al., Depression and long-term mortality risk in patients with coronary artery disease, Am J Cardiol, 78, pp. 613-617, (1996)

[10]

Bush D.E., Ziegelstein R.C., Tayback M., Richter D., Stevens S., Zahalsky H., Fauerbach J.A., Even minimal symptoms of depression increase mortality risk after acute myocardial infarction, American Journal of Cardiology, 88, 4, pp. 337-341, (2001)

← 1 2 3 4 5 →